AKT1 and early-onset autosomal dominant Alzheimer disease: The LF effect of p-AKT has also been found in other diseases, with Alzheimer’s disease patients having reduced levels of PI3K and p-AKT in peripheral blood lymphocyte solution, and significant improvements in all of these metrics with LF (52).